Why Drug Price Negotiation Has Staying Power
(By Drew Altman for Kaiser Family Foundation, published June 25, 2021) The fact that prescription drugs represent just 10% of national
Read More(By Drew Altman for Kaiser Family Foundation, published June 25, 2021) The fact that prescription drugs represent just 10% of national
Read More(By Phil Galewitz for NPR) When doctors at a primary care clinic in Philadelphia noticed many of its poorest patients
Read More(By Katie Adams for Becker’s Hospital Review) Biogen’s Alzeheimer’s drug Aduhelm could single-handedly represent 1 percent of all national healthcare
Read MoreAccording to a recent Edward Jones and Age Wave study, healthcare costs is the top money-related concerns for individuals retiring. The
Read More(By Katie Adams for Becker’s Hospital Review) As more drugs enter the market with five-figure annual list prices, a large
Read More(By Jay Hancock for Kaiser Health News) After falling from a ladder and cutting his arm, Ed Knight said, he
Read More(By Morgan Haefner for Becker’s Hospital Review) UnitedHealthcare is delaying a policy that could have led to retroactive denials for emergency
Read More(By Rachel Bluth for Kaiser Health News) It took covid-19 to give millions of Americans the option of telling their
Read More(By Bernard J. Wolfson for Kaiser Health News) In April, San Francisco-based primary care company One Medical revealed an eye-popping
Read More(By Juliette Cubanski and Anthony Damico for Kaiser Family Foundation published June 8, 2021) The Medicare Part D program provides
Read More